Loading…
Profound Medical Corp. is projected to rise to $8.56 by 2027, a +22% move from its current price of $7.04. PROF is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $6.87 | $7.04 | $7.22 | +0.06% |
| Jul 14 | $6.81 | $7.05 | $7.30 | +0.12% |
| Jul 15 | $6.76 | $7.05 | $7.36 | +0.18% |
| Jul 16 | $6.72 | $7.06 | $7.41 | +0.24% |
| Jul 17 | $6.68 | $7.06 | $7.46 | +0.30% |
| Jul 18 | $6.65 | $7.07 | $7.50 | +0.36% |
| Jul 19 | $6.62 | $7.07 | $7.54 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.62 | $7.07 | $7.54 | +0.42% |
| Week 2 | $6.48 | $7.10 | $7.78 | +0.83% |
| Week 3 | $6.37 | $7.13 | $7.98 | +1.25% |
| Week 4 | $6.29 | $7.16 | $8.15 | +1.67% |
| Week 5 | $6.22 | $7.19 | $8.31 | +2.10% |
| Week 6 | $6.16 | $7.22 | $8.46 | +2.52% |
| Week 7 | $6.10 | $7.25 | $8.61 | +2.95% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Profound Medical Corp operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. Its lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors.
It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
Profound Medical Corp is a healthcare stock focused on medical devices that integrate AI with MRI guidance for tissue ablation. The company markets TULSA-PRO and Sonalleve systems and operates in multiple countries.
A major floor 28.1% below — a decisive break under it would weaken the trend.
The nearest floor, 9.5% below — buyers have tended to step in here.
The nearest ceiling, 7.2% above — a clean break opens room to run.
A major ceiling 16.0% above — clearing it would confirm fresh momentum.
Key PROF support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PROF market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.35 | Sell | $7.20 | Sell |
| MA 10 | $7.00 | Buy | $7.07 | Sell |
| MA 20 | $6.81 | Buy | $6.92 | Buy |
| MA 50 | $6.84 | Buy | $6.80 | Buy |
| MA 100 | $6.63 | Buy | $6.73 | Buy |
| MA 200 | $6.65 | Buy | $6.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.95 | Neutral |
| Stoch RSI (14) | 44.98 | Neutral |
| CCI (20) | 56.33 | Neutral |
| Williams %R (14) | -43.22 | Info |
| MACD (12,26,9) | 0.08 | Buy |
| ROC (12) | 7.98 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 56.78 | Neutral |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | 0.57 | Buy |
| Ultimate (7,14,28) | 59.42 | Neutral |
| Momentum (10) | 0.67 | Buy |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 7.51 | Sell |
| ADX (14) | 13.40 | Neutral |
| ATR (14) | 0.16 | Info |
The current price is $7.37 per share with a market cap of $267.81M and a rank of 3561. The 30-day technical picture shows a bullish stance with a relative strength index (RSI) of 70 and moving averages above recent prices: the SMA50 is $6.80 and the SMA200 is $6.59. Near-term support sits at $6.37 and resistance at $7.37, with the 30-day range ranging from $6.25 to $8.69.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.06 | $7.04 | $9.79 | 0% | Neutral | |
| $6.88 | $8.56 | $11.23 | +22% | Bullish | |
| $8.05 | $10.26 | $13.93 | +46% | Bullish | |
| $10.31 | $13.43 | $18.71 | +91% | Bullish | |
| $10.87 | $14.41 | $20.54 | +105% | Bullish | |
| $11.65 | $15.71 | $22.83 | +123% | Bullish | |
| $12.43 | $17.01 | $25.15 | +142% | Bullish | |
| $12.41 | $17.23 | $25.89 | +145% | Bullish | |
| $15.26 | $21.47 | $32.73 | +205% | Bullish | |
| $18.15 | $25.88 | $39.99 | +268% | Bullish | |
| $23.16 | $35.01 | $57.29 | +397% | Bullish | |
| $46.77 | $78.08 | $138.94 | +10.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.06 | $7.04 | $8.41 | +0.00% |
| August 2026 | $6.23 | $7.33 | $8.85 | +4.14% |
| September 2026 | $6.27 | $7.43 | $9.06 | +1.37% |
| October 2026 | $6.19 | $7.37 | $9.06 | -0.78% |
| November 2026 | $6.33 | $7.58 | $9.38 | +2.78% |
| December 2026 | $6.54 | $7.86 | $9.79 | +3.69% |
Click any year to see its month-by-month PROF forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PROF price prediction for 2026 points to an average of $7.04 (low $5.06, high $9.79) — a potential gain of 0% on today's $7.04. Price action looks broadly range-bound.
In 2027, PROF is projected to trade between $6.88 and $11.23, averaging $8.56 — a potential gain of +22% from today's $7.04. That is up +22% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Profound Medical Corp.'s 2028 outlook centres on $10.26, within a $8.05 to $13.93 range. That is up +20% on the projected 2027 average. That marks a +46% change versus current levels. Momentum favours further upside here.
By 2029, PROF could reach as high as $18.71, with a base case around $13.43 and support toward $10.31 — roughly +91% from $7.04. Buyers look set to stay in control over this stretch.
Expect PROF to range from $10.87 to $20.54 through 2030. The $14.41 average target implies a +105% move from current prices. That is up +7% on the projected 2029 average. Momentum favours further upside here.
The PROF price prediction for 2031 points to an average of $15.71 (low $11.65, high $22.83) — a potential gain of +123% on today's $7.04. Buyers look set to stay in control over this stretch.
In 2032, PROF is projected to trade between $12.43 and $25.15, averaging $17.01 — a potential gain of +142% from today's $7.04. That is up +8% on the projected 2031 average. Momentum favours further upside here.
Profound Medical Corp.'s 2033 outlook centres on $17.23, within a $12.41 to $25.89 range. That is up +1% on the projected 2032 average. That marks a +145% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, PROF could reach as high as $32.73, with a base case around $21.47 and support toward $15.26 — roughly +205% from $7.04. Momentum favours further upside here.
Expect PROF to range from $18.15 to $39.99 through 2035. The $25.88 average target implies a +268% move from current prices. That is up +21% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The PROF price prediction for 2040 points to an average of $35.01 (low $23.16, high $57.29) — a potential gain of +397% on today's $7.04. Momentum favours further upside here.
In 2050, PROF is projected to trade between $46.77 and $138.94, averaging $78.08 — a potential gain of +10.1x from today's $7.04. That is up +123% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PROF today (≈ 142.045455 PROF) could be worth
$11,091.19
+$10,091.19 (+1009%) by 2050 · US Dollar
Based on the average projected PROF price of $78.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PROFwould be worth at today's price.
$1,000 invested in PROF on Jul 10, 2025 (≈ 164.473686 PROF) would be worth
$1,157.89
+$157.89 (+15.8%) today · 1.16× · US Dollar
Based on a PROF entry price of $6.08 vs. today's $7.04.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.81 | $1,033.77 | +3.4% |
| 1 month ago | $6.71 | $1,049.18 | +4.9% |
| 3 months ago | $5.95 | $1,183.19 | +18.3% |
| 6 months ago | $8.65 | $813.87 | -18.6% |
| 1 year ago | $6.08 | $1,157.89 | +15.8% |
| All time (5.0y) ago | $17.62 | $399.55 | -60.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PROF forecast.
Our base-case forecast reaches $14.00 around 2030.
Implied market cap at $14.00: $508.73M
The multi-year forecast shows a bullish trajectory after 2026, with the average price forecast rising from $7.37 in 2026 to $16.40 in 2030 and $100.08 by 2050. The implied ROI climbs from 0% in 2026 to 122.5% in 2030, 146.4% in 2031, 169.4% in 2032, 176.1% in 2033, 254% in 2034, 326.4% in 2035, 501.1% in 2040 and 1258% in 2050. Sentiment remains neutral in 2026 and becomes bullish from 2027 onward, with the forecasted price path indicating substantial upside potential over the long term.
These figures are estimates and may not reflect actual future results, which depend on market conditions and other factors.
Tap a question to reveal the answer.
2030 avg is $16.40 with a min of $12.33 and a max of $23.46. The ROI is 122.5% and the sentiment is bullish.
The forecast shows a rising average price through 2050, from $7.37 in 2026 to $100.08 in 2050, with ROI reaching 1258% by 2050. The sentiment is bullish for 2027–2050, but these are estimates and not guarantees.
The current price is $7.37 and the market cap is $267.81M.
2035 max is $48.81 and 2040 max is $72.91, with 2050 max at $179.31. This suggests the price could exceed $50 in the 2040–2050 window, but these are not guaranteed outcomes.
2030 avg $16.40; 2040 avg $44.30; 2050 avg $100.08. ROI progresses to 122.5% in 2030 and 1258% by 2050, with bullish sentiment from 2027 onward.
Profound Medical Corp. Community Discussion
0Share your Profound Medical Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.